The vaccinia virus C1 2L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model

Journal of General Virology

Volumn 83, Issue 11, 2002, Pages 2833-2844

  Symons, Julian A ^a   Adams, Elizabeth ^a   Tscharke, David C ^a   Reading, Patrick C ^a   Waldmann, Herman ^a   Smith, Geoffrey L ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; VIRUS DNA; VIRUS PROTEIN; C12L PROTEIN, VACCINIA VIRUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACULOVIRUS; BIOASSAY; CONTROLLED STUDY; DELETION MUTANT; DNA TRANSFER; ENZYME INHIBITION; GENE INSERTION; GENE MAPPING; HUMAN; HUMAN CELL; IN VITRO STUDY; LIFE CYCLE; MOUSE; NONHUMAN; NOSE INFECTION; NUCLEOTIDE SEQUENCE; POXVIRUS; PRIORITY JOURNAL; PROTEIN FUNCTION; SPLEEN CELL; SUPERNATANT; VACCINIA VIRUS; VIRUS ATTENUATION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CBA MOUSE; CELL CULTURE; CELL LINE; CERCOPITHECUS; CHROMOSOME MAP; CYTOLOGY; DISEASE MODEL; DRUG ANTAGONISM; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; METABOLISM; MOLECULAR GENETICS; PATHOGENICITY; PHYSIOLOGY; SPLEEN; TIME; VACCINIA; VIRULENCE;

ANIMALIA; DNA VIRUSES; INSERTION SEQUENCES; MURINAE; POXVIRIDAE; UNIDENTIFIED BACULOVIRUS; VACCINIA VIRUS;

ADMINISTRATION, INTRANASAL; ANIMALS; BASE SEQUENCE; CELL LINE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CHROMOSOME MAPPING; DISEASE MODELS, ANIMAL; DNA, VIRAL; GENE EXPRESSION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-18; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; POXVIRIDAE; SPLEEN; TIME FACTORS; VACCINIA; VACCINIA VIRUS; VIRAL PROTEINS; VIRULENCE; VIRUS REPLICATION;

EID: 0036826915     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-11-2833     Document Type: Article

References (61)

1. Afonso, C. L., Tulman, E. R., Lu, Z., Zsak, L., Osorio, F. A., Balinsky, C., Kutish, G. F. & Rock, D. L. (2002). The genome of swinepox virus. Journal of Virology 76, 783-790.
2. Alcamí, A. & Koszinowski, U. H. (2000). Viral mechanisms of immune evasion. Trends in Microbiology 8, 410-418.
3. Alcamí, A. & Smith, G. L. (1992). A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71, 153-167.
4. Alcamí, A. & Smith, G. L. (1995). Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. Journal of Virology 69, 4633-4639.
5. Alcamí, A. & Smith, G. L. (1996). A mechanism for the inhibition of fever by a virus. Proceedings of the National of Academy of Sciences, USA 93, 11029-11034.
6. Alcamí, A. & Smith, G. L. (2002). The vaccinia virus soluble interferon-γ receptor is a homodimer. Journal of General Virology 83, 545-549.
7. Alcamí, A., Symons, J. A., Collins, P. D., Williams, T. J. & Smith, G. L. (1998). Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. Journal of Immunology 160, 624-633.
8. Alcamí, A., Khanna, A., Paul, N. L. & Smith, G. L. (1999). Vaccinia virus strains Lister, USSR and Evans express soluble and cell surface tumour necrosis factors receptor. Journal of General Virology 80, 949-959.
9. Alcamí, A., Symons, J. A. & Smith, G. L. (2000). The vaccinia soluble IFN-α/β receptor binds to the cell surface and protects cells from the antiviral effects of IFN. Journal of Virology 74, 11230-11239.
10. Antoine, G., Scheiflinger, F., Dorner, F. & Falkner, F. G. (1998). The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244, 365-396.
11. Bartlett, N., Symons, J. A., Tscharke, D. C. & Smith, G. L. (2002). The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. Journal of General Virology 83, 1965-1976.
12. Beattie, E., Tartaglia, J. & Paoletti, E. (1991). Vaccinia-virus encoded eIF-2α homolog abrogates the antiviral effect of interferon. Virology 183, 419-422.
13. Born, T. L., Morrison, L. A., Esteban, D. J., VandenBos, T., Thebeau, L. G., Chen, N., Spriggs, M. K., Sims, J. E. & Buller, R. M. L. (2000). A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. Journal of Immunology 164, 3246-3254.
14. Chakrabarti, S., Brechling, K. & Moss, B. (1985). Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Molecular and Cellular Biology 5, 3403-3409.
15. Chang, H.-W., Watson, J. C. & Jacobs, B. L. (1992). The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proceedings of the National of Academy of Sciences, USA 89, 4825-4829,
16. Colamonici, O. R., Domanski, P., Sweitzer, S. M., Larner, A. & Buller, R. M. L. (1995). Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. Journal of Biological Chemistry 270, 15974-15978.
17. Comeau, M. R., Johnson, R., DuBose, R. F., Petersen, M., Gearing, P., VandenBos, T., Park, L., Farrah, T., Buller, R. M., Cohen, J. I., Strockbine, L. D., Rauch, C. & Spriggs, M. K. (1998). A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. Immunity 8, 473-482.
18. Davison, A. J. & Moss, B. (1990). New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins. Nucleic Acids Research 18, 4285-4286.
19. Falkner, F. G. & Moss, B. (1988). Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. Journal of Virology 62, 1849-1854.
20. Falkner, F. G. & Moss, B. (1990). Transient dominant selection of recombinant vaccinia viruses. Journal of Virology 64, 3108-3111.
21. Fantuzzi, G., Reed, D. A. & Dinarello, C. A. (1999). IL-12-induced IFN-gamma is dependent on caspase-1 processing of the IL- 18 precursor. Journal of Clinical Investigation 104, 761-767.
22. Gardner, J. D., Tscharke, D. C., Reading, P. C. & Smith, G. L. (2001). Vaccinia virus semaphorin A39R is a 50-55 kDa secreted glycoprotein that affects the outcome of infection in a murine intradermal model. Journal of General Virology 82, 2083-2093.
23. Gately, M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L., Gubler, U. & Presky, D. H. (1998). The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annual Review of Immunology 16, 495-521.
24. Graham, K. A., Lalani, A. S., Macen, J. L., Ness, T. L., Barry, M., Liu, L., Lucas, A., Clark-Lewis, I., Moyer, R. W. & McFadden, G. (1997). The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229, 12-24.
25. Hughes, S. J., Johnston, L. H., de Carlos, A. & Smith, G. L. (1991). Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae. Journal of Biological Chemistry 266, 20103-20109.
26. Kerr, S.M. & Smith, G. L. (1991). Vaccinia virus DNA ligase is nonessential for virus replication: recovery of plasmids from virus-infected cells. Virology 180, 625-632.
27. r 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model. Virology 206, 136-147.
28. Kettle, S., Alcamí, A., Khanna, A., Ehret, R., Jassoy, C. & Smith, G. L. (1997). Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1β-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1β-induced fever. Journal of General Virology 78, 677-685.
29. Kotwal, G. J. & Moss, B. (1988a). Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335, 176-178.
30. Kotwal, G. J. & Moss, B. (1988b). Analysis of a large cluster of nonessential genes deleted from a vaccinia virus terminal transposition mutant. Virology 167, 524-537.
31. Kotwal, G. J., Isaacs, S. N., McKenzie, R., Frank, M. M. & Moss, B. (1990). Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250, 827-830.
32. Lee, H. J., Essani, K. & Smith, G. L. (2001). The genome sequence of Yaba-like disease virus, a yatapoxvirus, Virology 281, 170-192.
33. Mackett, M., Smith, G. L. & Moss, B. (1985). The construction and characterization of vaccinia virus recombinants expressing foreign genes. In DNA Cloning: a Practical Approach, pp. 191-211. Edited by D. M. Glover. Oxford: IRL Press.
34. Moss, B., Winters, E. & Cooper, J. A. (1981). Deletion of a 9,000-base-pair segment of the vaccinia virus genome that encodes nonessential polypeptides. Journal of Virology 40, 387-395.
35. Mossman, K., Upton, C., Buller, R. M. & McFadden, G. (1995). Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins. Virology 208, 762-769.
36. Nakanishi, K., Yoshimoto, T., Tsutsui, H. & Okamura, H. (2001). lnterleukin-18 regulates both Th1 and Th2 responses. Annual Review of Immunology 19, 423-474.
37. Ng, A., Tscharke, D. C., Reading, P. C. & Smith, G. L. (2001). The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence. Journal of General Virology 82, 2095-2105.
38. Novick, D., Kim, S. H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A. & Rubinstein, M. (1999). Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10, 127-136.
39. Reading, P. C., Khanna, A. & Smith, G. L. (2002). Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence. Virology 292, 285-298.
40. Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S. B., Menon, S., Kastelein, R., Bazan, F. & O'Garra, A. (1997). IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 7, 571-581.
41. Shchelkunov, S. N., Safronov, P. F., Totmenin, A. V., Petrov, N. A., Ryazankina, O. I., Gutorov, V. V. & Kotwal, G. J. (1998). The genomic sequence analysis of the left and right species-specific terminal region of a cowpox virus strain reveals unique sequences and a cluster of intact ORFs for immunomodulatory and host range proteins. Virology 243, 432-460.
42. Shchelkunov, S. N., Totmenin, A. V., Babkin, I. V., Safronov, P. F., Ryazankina, O. I., Petrov, N. A., Gutorov, V. V., Uvarova, E. A., Mikheev, M. V., Sisler, J. R., Esposito, J. J., Jahrling, P. B., Moss, B. & Sandakhchiev, L. S. (2001). Human monkeypox and smallpox viruses: genomic comparison. FEBS Letters 509, 66-70.
43. Sims, J. E. (2002). IL-1 and IL-18 receptors, and their extended family. Current Opinion in Immunology 14, 117-122.
44. Smith, G. L. (2000). Secreted poxvirus proteins that interact with the immune system. In Effects of Microbes on the Immune System, 1st edn, pp. 491-507. Edited by M. W. Cunningham & R. S. Fujinami. Philadelphia: Lippincott Williams & Wilkins. Smith, G.L. & Chan, Y.S. (1991). Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily. Journal of General Virology 72, 511-518.
45. Smith, C. A., Davis, T., Anderson, D., Solam, L., Beckmann, M. P., Jerzy, R., Dower, S. K., Cosman, D. & Goodwin, R. G. (1990). A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248, 1019-1023.
46. Smith, C. A., Smith, T. D., Smolak, P. J., Friend, D., Hagen, H., Gernart, M., Park, L., Pickup, D. J., Torrance, D., Mohler, K., Schooley, K. & Goodwin, R. G. (1997). Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits β chemokine activity yet lacks sequence homology to known chemokine receptors. Virology 236, 316-327.
47. Smith, V. P., Bryant, N. A. & Alcamí, A. (2000). Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. Journal of General Virology 81, 1223-1230.
48. Spriggs, M., Hruby, D. E., Maliszewski, C. R., Pickup, D. J., Sims, J. E., Buller, R. M. L. & Vanslyke, J. (1992). Vaccinia and cowpox viruses encode a novel secreted interleukin-1 binding protein. Cell 71, 145-152.
49. Symons, J. A., Alcamí, A. & Smith, G. L. (1995). Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81, 551-560.
50. Symons, J. A., Tscharke, D. C., Price, N. & Smith, G. L. (2002). A study of the vaccinia virus interferon-γ receptor and its contribution to virus virulence. Journal of General Virology 83, 1953-1964.
51. Tanaka-Kataoka, M., Kunikata, T., Takayama, S., Iwaki, K., Ohashi, K., Ikeda, M. & Kurimoto, M. (1999). In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection. Cytokine 11, 593-599.
52. Tomonari, K. (1988). A rat antibody against a structure functionally related to the mouse T-cell receptor/T3 complex. Immunogenetics 28, 455-458.
53. Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J. & Ploegh, H. L. (2000). Viral subversion of the immune system. Annual Review of Immunology 18, 861-926.
54. Tscharke, D.C. & Smith, G. L. (1999). A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae. Journal of General Virology 80, 2751-2755.
55. Tscharke, D. C., Reading, P. C. & Smith, G. L. (2002). Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. Journal of General Virology 83, 1977-1986.
56. Upton, C., Mossman, K. & McFadden, G. (1992). Encoding of a homolog of IFN-γ receptor by myxoma virus. Science 258, 1369-1372.
57. Xiang, Y. & Moss, B. (1999a). IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. Proceedings of the National of Academy of Sciences, USA 96, 11537-11542.
58. Xiang, Y. & Moss, B. (1999b). Identification of human and mouse homologs of the MC51L-53L-54L family of secreted glycoproteins encoded by the molluscum contagiosum poxvirus. Virology 257, 297-302.
59. Xiang, Y. & Moss, B. (2001a). Correspondence of the functional epitopes of poxvirus and human interleukin-18-binding proteins. Journal of Virology 75, 9947-9954.
60. Xiang, Y. & Moss, B. (2001b). Determination of the functional epitopes of human interleukin-18-binding protein by site-directed mutagenesis. Journal of Biological Chemistry 276, 17380-17386.
61. Yoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S., Okamura, H., Akira, S. & Nakanishi, K. (1998). IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. Journal of Immunology 161,